No photos found.
The Shore Capital note shows how cheap FIN is compared to its peers.
This user has no comment yet.
No profile data added yet. |
No photos found.
The Shore Capital note shows how cheap FIN is compared to its peers.
The new areas are supercharging growth.
The broker is estimating the new ventures will add annualised revenue of £2m in year 1.
Edit
Excellent news. The card scheme launched last week and now the Dubai licence.
It looks like there will be a golden cross on the chart in the next few weeks.
I am expecting very strong growth in Q1 now that they are focused on the best performing states. I think we could get a 25% increase in prescriptions.
STX are starting to get great analyst coverage. Stifel are covering STX and it was them who upgraded their price target last week apparently.
Good questions.
Once this starts to scale the cash flows are very large compared to the market cap.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions